Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098369 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 444
- Enrollment target
NCT02098369 is a Phase 4 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 444 participants.
The verdict
NCT02098369, a Phase 4 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 444 participants
- Enrollment target
Study Summary
About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).
Interventions
- BEHAVIORAL Written education material (basic)
- BEHAVIORAL Additional education material
- BEHAVIORAL PELICAN-Proactive
- BEHAVIORAL PELICAN-Reactive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02098369
The ClinicalTrials.gov registry entry for NCT02098369 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 444 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Written education material (basic) is the first listed.
NCT02098369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02098369 about?
NCT02098369 is a clinical study titled "Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers". About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of th...
What is the current status of trial NCT02098369?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 444 participants. The study started on 2015-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02098369?
The interventions under investigation include: Written education material (basic) (BEHAVIORAL), Additional education material (BEHAVIORAL), PELICAN-Proactive (BEHAVIORAL), PELICAN-Reactive (BEHAVIORAL).
Who is sponsoring clinical trial NCT02098369?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.